AMSbiopharma, our specialized line of analytical solutions for the quality control of pharmaceutical products, announces the launch of a service for the analysis of nitrosamines in vitamin B12. This service, developed with state-of-the-art technology, makes a difference in the analytical services for…

This morning, the event to present the results of the R&D&I projects NANOFLUIDETEC and DIGITAL BIOCoV, within the framework of the CONECTA COVID 2021 programme, as part of the European Union’s response to the COVID-19 pandemic, was held in the…

In the AMSlab Group, we continue to be immersed in a series of changes that are taking place in accordance with the growth and evolution that we are experiencing. One of these changes consists of the acquisition of an industrial…

The project called Rapid and automatable detection for SARS-Cov-2 based on PCR, nanotechnology and microfluidics (NANOFLUIDETEC) is investigating the development of a detection system for SARS-CoV-2, the virus that causes the disease COVID-19, based on molecular techniques and integrating nanotechnology…